# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-011498
Filing Date
2021-02-25
Accepted
2021-02-25 07:57:15
Documents
12
Period of Report
2021-02-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea136471-6k_immuronltd.htm | 6-K | 12250
2 | HALF YEARLY REPORT AND ACCOUNTS | ea136471ex99-1_immuronltd.htm | EX-99.1 | 461687
3 | GRAPHIC | image_001.jpg | GRAPHIC | 1395
4 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 166479
5 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 172838
6 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 5147
7 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 6805
8 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 4711
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 176922
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 196965
11 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 3284
12 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 175502
| Complete submission text file | 0001213900-21-011498.txt |  | 1729805

Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 21676460
SIC: 2834 Pharmaceutical Preparations